Literature DB >> 8180375

Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells.

S D Lyman1, L James, L Johnson, K Brasel, P de Vries, S S Escobar, H Downey, R R Splett, M P Beckmann, H J McKenna.   

Abstract

Using a fragment of the murine flt3 ligand as a probe, we have succeeded in cloning a human flt3 ligand from a human T-cell lambda gt10 cDNA library. The human and murine ligands are 72% identical at the amino acid level. Analysis of multiple cDNA clones shows that alternative splicing of the human flt3 mRNA can occur at a number of positions. A recombinant soluble form of the human flt3 ligand stimulates the proliferation and colony formation of a subpopulation of human bone marrow cells that are CD34+ and are enriched for primitive hematopoietic cells. In addition, the human flt3 ligand also stimulates the proliferation of cells expressing murine flt3 receptors. Northern blot analysis shows widespread expression of flt3 ligand mRNA transcripts in human tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180375

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Flt3 ligand expands CD103⁺ dendritic cells and FoxP3⁺ T regulatory cells, and attenuates Crohn's-like murine ileitis.

Authors:  Colm B Collins; Carol M Aherne; Eóin N McNamee; Matthew D P Lebsack; Holger Eltzschig; Paul Jedlicka; Jesús Rivera-Nieves
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

Review 2.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

Review 3.  Chimerism after organ transplantation.

Authors:  T E Starzl; A J Demetris; N Murase; M Trucco; A W Thomson; A S Rao; J J Fung
Journal:  Curr Opin Nephrol Hypertens       Date:  1997-05       Impact factor: 2.894

4.  Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers.

Authors:  N Anandasabapathy; G Breton; A Hurley; M Caskey; C Trumpfheller; P Sarma; J Pring; M Pack; N Buckley; I Matei; D Lyden; J Green; T Hawthorne; H C Marsh; M Yellin; T Davis; T Keler; S J Schlesinger
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

Review 5.  Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens.

Authors:  Keith Pratz; Mark Levis
Journal:  Leuk Lymphoma       Date:  2008-05

6.  RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels.

Authors:  Anne L Astier; Gaëlle Beriou; Thomas M Eisenhaure; Stephen M Anderton; David A Hafler; Nir Hacohen
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

7.  Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration.

Authors:  Evert-Jan F M de Kruijf; Henny Hagoort; Gerjo A Velders; Willem E Fibbe; Melissa van Pel
Journal:  Haematologica       Date:  2010-01-15       Impact factor: 9.941

8.  Flt3-L increases CD4+CD25+Foxp3+ICOS+ cells in the lungs of cockroach-sensitized and -challenged mice.

Authors:  Halvor S McGee; Jehad H Edwan; Devendra K Agrawal
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-15       Impact factor: 6.914

9.  Attenuation of vaccinia virus by the expression of human Flt3 ligand.

Authors:  Kamila Zurkova; Petr Hainz; Jitka Krystofova; Luda Kutinova; Miloslav Sanda; Sarka Nemeckova
Journal:  Virol J       Date:  2010-05-26       Impact factor: 4.099

Review 10.  ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside.

Authors:  Jianbiao Zhou; Boon-Cher Goh; Daniel H Albert; Chien-Shing Chen
Journal:  J Hematol Oncol       Date:  2009-07-30       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.